Halda Therapeutics

Last updated: August 06, 2025

CEO - Tim Shannon
CEO - Tim Shannon
USA | Funding: $208.3M (+)

Website: https://haldatx.com

Halda is developing RIPTAC therapeutics - a new class of precision medicines to defeat cancer.